Umoja Biopharma
Umoja Biopharma Employees
15 people indexed:
-
Andrew Scharenberg
Co-founder & Chief Executive Officer
9x309t.20q0z3zq04z@73f10l56y27lz63.425 Sign up to see email2k77t2.459zz67z534@z4t6ql20v944f15.v9x Sign up to see email -
Branden Salinas
Executive Director, Process & Product Development
v959584.gf79579@86f95w03tz8g12k.8z2 Sign up to see email244tq52.tf8g8w9@85q58w286yq1g37.927 Sign up to see email -
w8q4f04.7dk8qg4@4yz9348kgqd59zk.0fv Sign up to see email
-
Byoung Ryu
EVP, Discovery Research & Vector Biology
1dl2t6.s96@88q8z1l25246xfx.4qf Sign up to see emailq1t6dq.740@xk6tezt3l00f8vw.xq9 Sign up to see email -
0dz27.zqxg5@g4td72zt524248v.yf7 Sign up to see email
-
47672.84d77@8ydy9w28ngw7d3f.knv Sign up to see email
-
2qlwz.x42k741@4yse67917q0sq5l.y3k Sign up to see email
-
Geoff Quinn
Vice President, Corporate Operations
4177w.s970s@2tws10497vy9t0l.tw1 Sign up to see email210w3.9w90s@wd0sk1s61623kwd.88k Sign up to see email -
xd4gd.v3x@qg1d8t0f48783q0.vyw Sign up to see email
-
Jacob Garcia
Vice President, Clinical Development & Operations
w1fzv.5fd1wy@n898wqedvysvyx1.z7l Sign up to see emailkzdzs.7v9w5q@69ndxdd22qzxv1d.3y7 Sign up to see email -
wxz93wdw.kq5v74@39xyw8291qdv466.4yy Sign up to see email
-
7w20w1x.y128@0d697d7t1zyz49q.69q Sign up to see email
-
Ryan Crisman
Co-founder & Chief Technical Officer
2e66.fxzf32x@q2wf64wx130wk04.fzl Sign up to see emailwzzw.zdx93qt@t01v79w3w1kge6v.5z2 Sign up to see email -
xf7v.531x7k@f188t5d0z1gw63k.2q3 Sign up to see email
-
Sally M. Dyer
SVP, General Manager, Colorado Operations
g3406.v.6x33@vtt10x6wgz310t0.103 Sign up to see emailq92ff.t.4k5g@kw997tgnwx64430.tv1 Sign up to see email
Umoja Biopharma Company Information
Umoja Biopharma is a biotechnology company focused on developing off-the-shelf therapeutics aimed at improving the reach, effectiveness, and accessibility of CAR T cell therapies in the fields of oncology and autoimmunity. The company employs its proprietary VivoVec in vivo gene delivery technology to enable a patient’s own immune system to combat disease more effectively. Umoja Biopharma operates a state-of-the-art lentiviral vector development and manufacturing facility located in Louisville, Colorado. The company has established strategic collaborations with AbbVie and IASO BIO to advance novel in-situ and ex vivo CAR-T cell therapies. Umoja Biopharma is headquartered at 1150 Eastlake Ave E, Suite 400, Seattle, WA 98109, with an additional location at 725 Tech Ct, Louisville, CO 80027.